CD274 and small cell lung carcinoma: Moreover, the combination of a PD-1/PD-L1 inhibitor and chemotherapeutic agents such as cisplatin significantly increased the prognosis of extensive-stage small-cell lung cancer (ES-SCLC) without raising AEs [84].